The rise of AI in health care presents new challenges related to the patentability and regulation of AI-driven medical ...

SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential ...

A device in clinical development appears to be far safer and more effective than the TAVI devices currently being used ...

Discover how Donald Trump's tariffs and policies could impact essential aspects of daily life for middle-class Americans, ...

Venova Medical announced the completion of patient enrollment for the company’s VENOS-2 early feasibility study. Accordi ...

SeaStar Medical (ICU) announced that the U.S. Food and Drug Administration, FDA, has granted SeaStar Medical two new Breakthrough Device ...

Ventris Medical, a privately held orthobiologics and tissue regeneration company, today announced that the United States Food ...

Nasdaq Listing Rule 5550 (a) (2) requires listed securities to maintain a minimum bid price of US$1.00 per share, and Nasdaq Listing Rule 5810 (c) (3) (A) provides that a failure to meet the minimum ...

The lawsuit alleges safety cover-ups and fraudulent billing against the company behind the organ transplant device previously ...

The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with ...

Unsafe product recalls are alarmingly common. While all companies have a legal obligation to ensure that their products are ...

LuX-Valve TTVR was performed via the transatrial approach, resulting in a procedural success rate of 97.6%, with one patient ...